| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.19 | 7e-05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0003 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |